Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation in leukemia

R P Gale

    Annals of Clinical Research
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Bone marrow transplantation offers improved survival for certain leukemias, particularly acute myelogenous leukemia in remission. However, challenges like leukemic relapse and graft-versus-host disease persist, requiring further research.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.

    Blood·2001
    Same author

    Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.

    Blood·2000
    Same author

    Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County.

    Leukemia research·2000
    Same author

    Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

    Blood·2000
    Same author

    T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.

    Blood·2000
    Same author

    Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia.

    Blood·2000
    Same journal

    Dietary lipids and ischaemic heart disease--progress in 20 years.

    Annals of clinical research·1988
    Same journal

    Exercise prescription in medical practice.

    Annals of clinical research·1988
    Same journal

    More exercise for the hyperlipidaemic patients?

    Annals of clinical research·1988
    Same journal

    More exercise for the hypertensives?

    Annals of clinical research·1988
    Same journal

    More exercise for the obese?

    Annals of clinical research·1988
    Same journal

    Physical activity and effects of muscle training in the elderly.

    Annals of clinical research·1988
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Transplantation Medicine

    Background:

    • Bone marrow transplantation (BMT) has been investigated for resistant acute leukemia over the past decade.
    • Current BMT approaches show superior disease-free survival compared to alternatives for resistant acute leukemia.

    Purpose of the Study:

    • To evaluate the efficacy of BMT in patients with leukemia in remission.
    • To assess the outcomes of autologous BMT for acute leukemia.
    • To review BMT outcomes in chronic myelogenous leukemia.

    Main Methods:

    • Review of data from multiple centers studying BMT in acute and chronic leukemia.
    • Analysis of survival rates, disease-free survival, leukemic relapse, and graft-versus-host disease.

    Related Experiment Videos

    Main Results:

    • Two-year disease-free survival for resistant acute leukemia is 10-20%.
    • BMT in remission improves survival for acute lymphoblastic leukemia, but relapse is common.
    • Acute myelogenous leukemia patients transplanted in remission show >50% two-year disease-free survival with low relapse rates.
    • Autologous BMT for acute leukemia has yielded disappointing results with high relapse rates.
    • BMT in the chronic phase of chronic myelogenous leukemia shows encouraging results, unlike transplantation during the acute phase.

    Conclusions:

    • Bone marrow transplantation plays an evolving role in treating acute and chronic leukemia.
    • Controlled clinical trials are necessary for a definitive evaluation of BMT utility.
    • Further research is needed to overcome challenges like leukemic relapse and graft-versus-host disease.